首页 | 本学科首页   官方微博 | 高级检索  
检索        

膀胱移行细胞癌DBCCR1基因启动子甲基化分析
引用本文:米军,段建敏,岳中瑾,张建平,李朝明.膀胱移行细胞癌DBCCR1基因启动子甲基化分析[J].兰州医学院学报,2006,32(1):1-3.
作者姓名:米军  段建敏  岳中瑾  张建平  李朝明
作者单位:兰州大学第二医院,泌尿外科,甘肃,兰州,730030;兰州长风医院泌尿外科,甘肃,兰州,730060;陇南市第一医院泌尿外科,甘肃,陇南,746000
摘    要:目的探讨膀胱移行细胞癌DBCCR1基因启动子甲基化状态及其临床意义。方法应用甲基化特异性PCR方法检测40例膀胱移行细胞癌和8例正常膀胱粘膜组织中DBCCRI基因甲基化程度,x^2检验分析其甲基化程度与膀胱癌病理分级分期之间的关系。结果正常膀胱组织未检测到DBCCR1基因启动子甲基化,在膀胱移行细胞癌启动子甲基化扩增阳性化率达42.5%,与膀胱癌病理分级分期没有相关性(P〉0.05)。结论DBCCR1基因启动子异常高甲基化是其失活的主要机制之一,也是膀胱移行细胞癌中一早期事件。

关 键 词:膀胱移行细胞癌  DBCCR1基因  甲基化
文章编号:1000-2812(2006)01-0001-03
收稿时间:2005-12-20
修稿时间:2005年12月20

Analysis of promoter methylation of DBCCR1 gene in bladder transitional cell carcinoma
MI Jun, DUAN Jian-min, YUE Zhong-jin, ZHANG Jian-ping, LI Zhao-ming.Analysis of promoter methylation of DBCCR1 gene in bladder transitional cell carcinoma[J].Journal of Lanzhou Medical College,2006,32(1):1-3.
Authors:MI Jun  DUAN Jian-min  YUE Zhong-jin  ZHANG Jian-ping  LI Zhao-ming
Institution:1. Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, 730030, China; 2. Changfen Hospital of Lanzhou City, Lanzhou, 730060, China; 3. The First Hospital of Longnan City, Longnan, 736000, Gansu, China
Abstract:Objective To evaluate promoter methylation of DBCCRl and its clinical significance. Methods DBCCRl methylation was examined in 40 cases of BTCC and 8 cases of normal urothelium by methylation specific PCR, x2 test was used to assess the relationship between the degree of methylation and tumor stage. Results DBCCRl methylation was found in 42.5%(17 of 40) cancer tissues and in 0%(0 of 8) normal urothelium. There was no significant difference between tumor grade and stage(P > 0.05). Conclusion Aberrant promoter hypermethylation is one of the mechanisms for inactivation of DBCCRl gene and an early event in bladder transitional cell carcinoma.
Keywords:bladder transitional cell carcinoma  DBCCR1 gene  methylation
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号